UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$361M |
| 2 |
Microsoft
MSFT
|
+$311M |
| 3 |
TAL Education Group
TAL
|
+$292M |
| 4 |
Salesforce
CRM
|
+$248M |
| 5 |
Apple
AAPL
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$530M |
| 2 |
Meta Platforms (Facebook)
META
|
+$215M |
| 3 |
Eli Lilly
LLY
|
+$150M |
| 4 |
AET
Aetna Inc
AET
|
+$110M |
| 5 |
LyondellBasell Industries
LYB
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.78% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Globus Medical
GMED
$11.2B
| $11M | 0.01% |
221,693
-642
| -0.3% | -$30.2K |
|
877
AutoNation
AN
$6.92B
| $11M | 0.01% |
234,212
+16,903
| +8% | +$904K |
|
|
BLUE
878
DELISTED
bluebird bio
BLUE
| $10.8M | 0.01% |
4,875
-446
| -8% | -$1.13M |
|
|
UN
879
DELISTED
Unilever NV New York Registry Shares
UN
| $10.8M | 0.01% |
190,650
+7,360
| +4% | +$404K |
|
880
Bank OZK
OZK
$5.61B
| $10.7M | 0.01% |
222,317
+20,173
| +10% | +$1.02M |
|
|
EFOR
881
Everforth Inc
EFOR
$1.32B
| $10.7M | 0.01% |
130,862
-1,607
| -1% | -$120K |
|
882
Sumitomo Mitsui Financial
SMFG
$164B
| $10.7M | 0.01% |
1,256,073
+364,209
| +41% | +$3.25M |
|
|
GRA
883
DELISTED
W.R. Grace & Co.
GRA
| $10.5M | 0.01% |
170,835
+4,351
| +3% | +$298K |
|
884
Louisiana-Pacific
LPX
$5.49B
| $10.4M | 0.01% |
362,654
+14,108
| +4% | +$404K |
|
885
Evolent Health
EVH
$444M
| $10.4M | 0.01% |
730,914
-20,986
| -3% | -$300K |
|
886
iShares MBS ETF
MBB
$39.1B
| – | – |
0
| – | – |
|
887
Sunstone Hotel Investors
SHO
$2.06B
| $10.3M | 0.01% |
675,925
+129,057
| +24% | +$2.02M |
|
|
888
Broadcom
AVGO
$2.04T
| $10.2M | 0.01% |
431,770
-21,058,880
| -98% | -$530M |
|
889
Ryman Hospitality Properties
RHP
$7.63B
| $10.2M | 0.01% |
131,315
+24,364
| +23% | +$1.78M |
|
|
JBGS
890
JBG SMITH
JBGS
$708M
| $10.1M | 0.01% |
300,777
+44,551
| +17% | +$1.48M |
|
891
First Industrial Realty Trust
FR
$8.44B
| $10.1M | 0.01% |
346,449
+64,514
| +23% | +$1.9M |
|
892
Charles River Laboratories
CRL
$12.8B
| $10.1M | 0.01% |
94,627
-224
| -0.2% | -$24.1K |
|
893
Cousins Properties
CUZ
$4.88B
| $10M | 0.01% |
288,263
+57,717
| +25% | +$2.02M |
|
894
Shake Shack
SHAK
$2.87B
| $10M | 0.01% |
240,388
-4,900
| -2% | -$204K |
|
|
HR
895
DELISTED
Healthcare Realty Trust Incorporated
HR
| $9.93M | 0.01% |
358,521
+56,705
| +19% | +$1.62M |
|
|
BPMC
896
DELISTED
Blueprint Medicines
BPMC
| $9.9M | 0.01% |
108,004
-1,784
| -2% | -$154K |
|
|
DOC
897
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $9.82M | 0.01% |
630,660
+90,138
| +17% | +$1.41M |
|
898
Teradyne
TER
$59.3B
| $9.81M | 0.01% |
214,689
+21,416
| +11% | +$980K |
|
899
iShares MSCI Switzerland ETF
EWL
$2.23B
| $9.8M | 0.01% |
285,000
| – | – |
|
|
CXP
900
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $9.76M | 0.01% |
477,159
+68,065
| +17% | +$1.45M |
|
Similar funds
UBS AM's Q1 2018 Portfolio in Review
As of Q1 2018, UBS AM held 2,716 positions worth $127B, up 7.4% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM deployed $8.54B of net new capital in Q1 2018, opening 143 new positions and adding to 1,776 existing holdings. Its largest new stake was Nutrien: 1,905,754 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Broadcom, an estimated $530M trimmed.
- UBS AM's largest Q1 2018 buy was Nutrien: 1,905,754 shares worth $90M.
- UBS AM added most to Alibaba in Q1 2018, an estimated $361M increase.
- UBS AM's biggest Q1 2018 reduction was Broadcom, cutting an estimated $530M.
- UBS AM fully exited Agrium in Q1 2018, selling an estimated $37.4M.
- UBS AM's ten largest holdings make up 17% of its $127B portfolio in Q1 2018.
- UBS AM opened 143 new positions and closed 63 in Q1 2018.
- UBS AM's portfolio value rose 7.4% quarter-over-quarter to $127B.
Based on UBS AM's 13F filing for Q1 2018, filed 14 May 2018.